Cargando…
Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study
BACKGROUND: Data are scarce regarding real-world health care resource use (HCRU) for non-small cell lung cancer (NSCLC). An understanding of current clinical practices and HCRU is needed to provide a benchmark for rapidly evolving NSCLC management recommendations and therapeutic options. The objecti...
Autores principales: | Lee, Dae Ho, Isobe, Hiroshi, Wirtz, Hubert, Aleixo, Sabina Bandeira, Parente, Phillip, de Marinis, Filippo, Huang, Min, Arunachalam, Ashwini, Kothari, Smita, Cao, Xiting, Donnini, Nello, Woodgate, Ann-Marie, de Castro, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831211/ https://www.ncbi.nlm.nih.gov/pubmed/29490654 http://dx.doi.org/10.1186/s12913-018-2946-8 |
Ejemplares similares
-
Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study
por: Lee, Dae Ho, et al.
Publicado: (2018) -
Systemic therapy treatment patterns in patients with advanced non‐small cell lung cancer (NSCLC): PIvOTAL study
por: de Castro, J., et al.
Publicado: (2017) -
The Piv-Otal Class II Transactivator Promoter Regulates Major Histocompatibility Complex Class II Expression in the Thymus
por: Honey, Karen, et al.
Publicado: (2001) -
Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan
por: Isobe, Hiroshi, et al.
Publicado: (2017) -
Immunohistochemistry analysis of pulmonary infiltrates in necropsy samples of children with non-pandemic lethal respiratory infections (RSV; ADV; PIV1; PIV2; PIV3; FLU A; FLU B)
por: de Souza Costa, Victor Horácio, et al.
Publicado: (2014)